Robert S. Landsman

Array ( [id] => 9273562 [patent_doc_number] => 08637494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Method of achieving normoglycemia in diabetics by administration of Withaferin A' [patent_app_type] => utility [patent_app_number] => 13/160334 [patent_app_country] => US [patent_app_date] => 2011-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 49 [patent_no_of_words] => 13836 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13160334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8675467 [patent_doc_number] => 08383580 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-26 [patent_title] => 'Methods of administering lipocalins to treat metabolic disorders and cardiovascular diseases' [patent_app_type] => utility [patent_app_number] => 13/157977 [patent_app_country] => US [patent_app_date] => 2011-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 59 [patent_no_of_words] => 17202 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13157977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8577900 [patent_doc_number] => 08344110 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-01 [patent_title] => 'Antibodies to thymic stromal lymphopoietin (TSLP) receptor molecules and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/156106 [patent_app_country] => US [patent_app_date] => 2011-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 20 [patent_no_of_words] => 35096 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13156106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8386156 [patent_doc_number] => 08263554 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Methods of using GLP-1 receptor agonists to treat pancreatitis' [patent_app_type] => utility [patent_app_number] => 13/155211 [patent_app_country] => US [patent_app_date] => 2011-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 10271 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13155211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7711028 [patent_doc_number] => 20120003681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'EX VIVO METHOD FOR DETERMINING POTENTIAL GLP-2 RECEPTOR MODULATIONS' [patent_app_type] => utility [patent_app_number] => 13/154071 [patent_app_country] => US [patent_app_date] => 2011-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3559 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13154071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7579756 [patent_doc_number] => 20110293639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'IDEOTYPICALLY MODULATED PHARMACOEFFECTORS FOR SELECTIVE CELL TREATMENT' [patent_app_type] => utility [patent_app_number] => 13/116747 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10948 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20110293639.pdf [firstpage_image] =>[orig_patent_app_number] => 13116747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7560851 [patent_doc_number] => 20110274683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'Antibodies That Bind CSF1R' [patent_app_type] => utility [patent_app_number] => 13/100990 [patent_app_country] => US [patent_app_date] => 2011-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 24868 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20110274683.pdf [firstpage_image] =>[orig_patent_app_number] => 13100990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7500408 [patent_doc_number] => 20110262937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'T1R HETERO-OLIGOMERIC TASTE RECEPTORS AND CELL LINES THAT EXPRESS SAID RECEPTORS AND USE THEREOF FOR IDENTIFICATION OF TASTE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/099327 [patent_app_country] => US [patent_app_date] => 2011-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 30209 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262937.pdf [firstpage_image] =>[orig_patent_app_number] => 13099327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8696942 [patent_doc_number] => 20130058951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'ANTI-S1P ANTIBODY TREATMENT OF PATIENTS WITH OCULAR DISEASE' [patent_app_type] => utility [patent_app_number] => 13/695287 [patent_app_country] => US [patent_app_date] => 2011-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10599 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10038163 [patent_doc_number] => 09078857 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-14 [patent_title] => 'Compositions comprising inhibitors of EPH receptor expression in tumor stem cells and methods of treatment thereof' [patent_app_type] => utility [patent_app_number] => 13/089217 [patent_app_country] => US [patent_app_date] => 2011-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 72 [patent_no_of_words] => 15942 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13089217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9552239 [patent_doc_number] => 08759287 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-24 [patent_title] => 'Methods of decreasing incisional hernia formation and acute wound failure in obese patients by administering basic fibroblast growth factor' [patent_app_type] => utility [patent_app_number] => 13/084908 [patent_app_country] => US [patent_app_date] => 2011-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8758 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13084908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8016983 [patent_doc_number] => 08137994 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-20 [patent_title] => 'Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof' [patent_app_type] => utility [patent_app_number] => 13/066280 [patent_app_country] => US [patent_app_date] => 2011-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2896 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/137/08137994.pdf [firstpage_image] =>[orig_patent_app_number] => 13066280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8016981 [patent_doc_number] => 08137993 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-20 [patent_title] => 'Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof' [patent_app_type] => utility [patent_app_number] => 13/066255 [patent_app_country] => US [patent_app_date] => 2011-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2898 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/137/08137993.pdf [firstpage_image] =>[orig_patent_app_number] => 13066255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8054069 [patent_doc_number] => 20120076770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'Modulation of autophagy and and serotonin for treatment of multiple myeloma related diseases' [patent_app_type] => utility [patent_app_number] => 13/073989 [patent_app_country] => US [patent_app_date] => 2011-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5061 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20120076770.pdf [firstpage_image] =>[orig_patent_app_number] => 13073989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7697085 [patent_doc_number] => 20110229505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'Methods for the diagnosis and treatment of cancer based on AVL9' [patent_app_type] => utility [patent_app_number] => 13/051701 [patent_app_country] => US [patent_app_date] => 2011-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20317 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229505.pdf [firstpage_image] =>[orig_patent_app_number] => 13051701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8685034 [patent_doc_number] => 20130053318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'MODULATING AQUAPORINS WITH RELAXIN' [patent_app_type] => utility [patent_app_number] => 13/582478 [patent_app_country] => US [patent_app_date] => 2011-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17549 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13582478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8648822 [patent_doc_number] => 20130034552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-07 [patent_title] => 'TEMPERATURE SENSITIVE CONJUGATE COMPOSITIONS, AND USES RELATED THERETO' [patent_app_type] => utility [patent_app_number] => 13/583055 [patent_app_country] => US [patent_app_date] => 2011-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17453 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13583055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8566500 [patent_doc_number] => 20120329071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'PROTEIN BIOMARKERS AND THERAPEUTIC TARGETS FOR RENAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/581939 [patent_app_country] => US [patent_app_date] => 2011-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16429 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13581939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8294235 [patent_doc_number] => 08222019 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Cell lines expressing T1R2/T1R3 hetero-oligomeric taste receptors and assay system thereof for identification of taste compounds' [patent_app_type] => utility [patent_app_number] => 13/036723 [patent_app_country] => US [patent_app_date] => 2011-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 23 [patent_no_of_words] => 30274 [patent_no_of_claims] => 120 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 232 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13036723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8189249 [patent_doc_number] => 08183201 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Methods of treating αvβ3 integrin-associated diseases by administering polypeptides selective for αvβ3 integrin' [patent_app_type] => utility [patent_app_number] => 13/035579 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 42 [patent_no_of_words] => 20486 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/183/08183201.pdf [firstpage_image] =>[orig_patent_app_number] => 13035579 [rel_patent_id] =>[rel_patent_doc_number] =>)